Seyyed Hossein Mousavi
1, Seyyed Reza Raeeskarami
2, Vahideh Laleh far
3, Reza Mollazadeh
3*1 Department of Cardiology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran
2 Department of Pediatrics, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: *Corresponding Author: Reza Mollazadeh, MD; Department of Cardiology, Imam Khomeini Hospital Complex, Tohid Sq., Tehran 1419733141, Iran. Tel: +98- 912-7334136; Fax: +98-21-66939537; Email: , Email:
mollazar@yahoo.com, r-molazadeh@sina.tums.ac.ir
Abstract
Since the emergence of novel coronavirus and the disease named as COVID-19 in late December of 2019 in Wuhan, Hubei province, China, many aspects of this disease have been reported in the literature (mainly pulmonary manifestations). In patients with COVID-19, rheumatic and cardiovascular manifestations and interactions were reported separately, but they were all very rare. This is the report of a 14-year-old teenager with GPA (previously known as Wegner’s granulomatosis) who was in remission with immunosuppressive therapy. Post COVID-19 infection, she developed exacerbation of her disease. Besides the rheumatologic manifestations, she developed epigastric pain found to be acute myocardial infarction (MI) that needed primary percutaneous coronary intervention (PCI).